Navigation Links
Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Second Phase 3 Study in Central Retinal Vein Occlusion
Date:4/27/2011

s of the eye (wet age-related macular degeneration, central retinal vein occlusion, and diabetic macular edema), and certain cancers.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic and immune conditions, and cancer.  Additional information about Regeneron and recent news releases are available on Regeneron's web site at www.regeneron.com.

About Bayer HealthCare

The Bayer Group is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials.  Bayer HealthCare, a subgroup of Bayer AG with annual sales of more than EUR 16.913 billion (2010), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany.  The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions.  Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide.  Bayer HealthCare has a global workforce of 55.700 employees and is represented in more than 100 countries.  Find more information at www.bayerhealthcare.com.

Regeneron Forward-Looking Statements

This news release includes forward-looking statements that involve risks and uncertainties relating to future events and the future financial performance of Regeneron, and actual events or results may differ materially from these forward-looking statements.  These statements concern, and these risks and uncertainties include, among others, the nature, timing, and possible success and therapeutic applications of Regeneron's produ
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
2. Regeneron Announces Presentation at the 10th Annual Needham Healthcare Conference
3. Sanofi-aventis and Regeneron Report Top-line Results from Phase III Study with aflibercept (VEGF Trap) in Second-Line Non-Small Cell Lung Cancer
4. Regeneron Announces March 2011 Investor Conference Presentations
5. Regeneron Submits Biologics License Application to FDA for VEGF Trap-Eye for Treatment of Wet Age-Related Macular Degeneration
6. Regeneron Reports Full Year and Fourth Quarter 2010 Financial and Operating Results
7. Regeneron to Webcast Investor Briefing on VEGF Trap-Eye Clinical Program on Sunday, February 13th at 9 am ET
8. Regeneron Announces Presentation at the ISI Annual Conference
9. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
10. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
11. Christine A. Poon Elected to Regeneron Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... -- Quietly, sedately, Morocco,s pharmaceutical sector is ... industry is strong, with a well-developed base of local ... One place where the quality of Moroccan ... has quietly become the second largest African exporter of ... Indeed, Moroccan pharma companies have been making inroads as ...
(Date:7/31/2015)... According to a new market ... Analyzers (BIA), Dual-Energy X-ray Absorptiometry (DEXA), Skinfold Calipers, Air ... & Forecast to 2019", published by MarketsandMarkets, the global ... 2014 and is estimated to grow to $1,425.7 Million ... 2014 to 2019. Browse 41 market ...
(Date:7/30/2015)... 30, 2015 IRIDEX Corporation (NASDAQ: IRIX ... quarter 2015 financial results after the market closes on ... the release, the Company will host a conference call ... Time on Thursday, August 6, 2015 ... business developments. Interested parties may access the ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 2Body Composition Analyzers Market Worth $1,425.7 Million by 2019 3Body Composition Analyzers Market Worth $1,425.7 Million by 2019 4IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2
... June 16, 2011 The largest human dermal allograft available ... will be introduced at the AWR meeting here this week. ... is introducing FlexHD acellular hydrated dermal matrix 20 ... cm x 25 cm grafts. FlexHD ...
... our scope of services, Shenzhen Wuzhou Changlian International Trading ... with a city hospital in the Southeast of Africa soon, ... equipment. Wuzhou Changlian has offered specialty body-care products ... which puts a focus on meeting local people,s needs and ...
Cached Medicine Technology:Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011 2Shenzhen Wuzhou Changlian International Trading Co. Establishes Relationship with Hospital in Africa 2
(Date:7/31/2015)... ... July 31, 2015 , ... Sculpted Contours Luxury Medical Aesthetics announces the arrival ... Zeltiq Aesthetics released this new applicator in the United States as an upgrade to ... thighs. The original applicator required a 2 hour treatment time. The new ...
(Date:7/31/2015)... Jacksonville, FL (PRWEB) , ... July 31, 2015 ... ... has announced an important workshop at its new True North Conference Center. The ... attend so that the Jacksonville community may be more aligned in the effort ...
(Date:7/31/2015)... ... 2015 , ... Coco Libre announced today that their flagship Organic Coconut Water ... Vans US Open of Surfing, July 25 through August 2 in Huntington Beach, California. ... the market, is a natural choice given the Open’s commitment to sustainable practices. ...
(Date:7/31/2015)... , ... July 31, 2015 , ... Ticket Down is ... Those looking to catch a new and refreshing show on Broadway, look no ... and achievements including an Obie Award, Outer Critics Circle Award, Drama Desk Award, Lucille ...
(Date:7/31/2015)... ... July 31, 2015 , ... According to an article published ... if they could reach a consensus on the steps that need to be taken ... group reached 90 percent consensus on a series of steps that each surgeon must ...
Breaking Medicine News(10 mins):Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 2Health News:Cooler Coolsculpting in Atlanta: Treatments Now Twice As Fast 3Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 2Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 3Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 4Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 5Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 6Health News:Cheap Hamilton Tickets at Richard Rodgers Theatre: Ticket Down Slashes Ticket Prices for Hamilton in New York City at the Richard Rodgers Theatre 7Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3
... research and the potential use of human embryonic stem ... splits both scientific and public opinion. The current conflict ... with the ethical implications of this promising, but delicate ... its early stages of development. It is a symbolic ...
... Fla., June 25 Pharmavite, a ... chosen the on-line consumer-centric,program, LearnSomethingAbout(TM), as ... created the engaging, consumer-oriented multimedia,program that ... national retailers., "LearnSomething shares similar ...
... Dr. Hilton Becker M.D.,F.A.C.S., F.R.C.S. of Boca Raton, Florida, ... 20 years, has created his most effective,implant yet -- the ... adjust in both shape and size after it has been ... are disappointed with,the shape and size of the breast after ...
... full $25 million of required financing now ... 25 /PRNewswire-FirstCall/ - Bioniche Life Sciences,Inc. (TSX: ... announced that it has secured an amendment,to ... the Industrial,Technologies Office of Industry Canada that ...
... PARSIPPANY, N.J., June 25 DSM,Biologics and Crucell ... that they have entered into an agreement with ... Vendor Network. Under,the terms of the agreement, Avid ... of the PER.C6(R) cell line located in the,western ...
... pressure checks can help control hypertension without office visits, ... of more than 700 Group Health patients published in ... Association . , "To our knowledge, this is ... care and a patient-shared electronic medical record to improve ...
Cached Medicine News:Health News:Stem cell research from an ethical point of view 2Health News:Pharmavite Partners With LearnSomething, Inc. on Consumer Education Program, LearnSomethingAbout(TM) 2Health News:Boca Raton Based Plastic Surgeon Introduces Revolutionary New Adjustable Breast Implant to Europe and Asia 2Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 2Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 3Health News:Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production 4Health News:DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins 2Health News:DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins 3Health News:DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins 4Health News:DSM and Crucell Sign Agreement with Avid Bioservices to Serve as First Pre-Approved U.S. Contract Manufacturer of PER.C6(R) Cell Line Proteins 5Health News:New online care for hypertension gets results 2
... an integrated system that will perform venous ... it. You no longer need to manually ... inflow with and without reactive hyperemia are ... time for measurements and the frequency with ...
... of an exciting new range of ... Coherence Reflectometry) technology,our Slitlamp-mounted* Pachymeter offers ... and this non-contact.,This allows pachymetry ... time,and without concerns about sterilization, false ...
... The Paradigm Pachymetric Analyzer is designed ... employing unique digital signal processing algorithms. During ... a reading if the probe is +1.5 ... assured of highly accurate results, every time. ...
... a minimally invasive cryocatheter to treat ... a very high level of safety ... precision, minimal tissue disruption, and minimal ... is a flexible, single-use, minimally invasive ...
Medicine Products: